Pfizer and Mylan have entered an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan. Pfizer is responsible for the commercialization of the combined generics portfolio, managing a combined marketing and sales effort. Mylan is responsible for managing operations, including R&D and manufacturing. The collaboration will include a portfolio of more than 350 marketed products across a range of therapeutic areas, as well as more than 1...